Join to View Full Profile
2714 Westwood Ave.Nashville, TN 37212
Phone+1 615-554-7461
Dr. Breyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Breyer is a nephrologist based in Indianapolis, IN with extensive expertise in general nephrology, diabetic nephropathy, kidney tubule function, cyclooxygenase 2, and prostaglandin E receptors. He completed his medical education at Harvard Medical School and specialized training in nephrology through a fellowship at the University of Texas Southwestern Medical Center. Dr. Breyer has held key positions such as Distinguished Scientist at Janssen from 2018-2025 and Chief Scientific Officer at Eli Lilly from 2009-2017. His career includes over two decades as a professor at Vanderbilt University School of Medicine. Dr. Breyer has contributed significantly to academic research, authoring several published studies focusing on molecular categorization of human chronic kidney disease and renal therapy responses.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Nephrology, 1982 - 1985
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1979 - 1982
Harvard Medical SchoolClass of 1979
Certifications & Licensure
TN State Medical License 1986 - 2023
Publications & Presentations
PubMed
- 16 citationsUnbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.Anna Reznichenko, Viji Nair, Sean Eddy, Damian Fermin, Mark Tomilo
Kidney International. 2024-06-01 - 3 citationsProstacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I 2 Receptor.Jing Li, Yi Guan, Yunyu Xu, Yingxue Cao, Qionghong Xie
Journal of the American Society of Nephrology. 2024-02-01 - 152 citationsMapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies.Haojia Wu, Romer Gonzalez Villalobos, Xiang Yao, Dermot Reilly, Tao Chen
Cell Metabolism. 2022-07-05
Authored Content
- Kidney InternationalApril 2017
Grant Support
- Ppars In CYP450 Dependent Regulation Of Kidney FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Cyclooxygenase Stimulated Neovascularization In DiabeticNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Regulation Of Renal Function By PGE2 And Pgf2a ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Generating Mouse Mutants With Diabetic NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2006
- Regulation Of Na+ Of Absorption On Renal PGE2 ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
